Read + Share
Williams T, Chataway J. Beyond ocrelizumab in primary progressive multiple sclerosis. Nat Rev Neurol 2022 Sep 22. pii: 10.1038/s41582-022-00724.
PMID: 36138171
|
 |
|
Williams T, Chataway J. Beyond ocrelizumab in primary progressive multiple sclerosis. Nat Rev Neurol 2022 Sep 22. pii: 10.1038/s41582-022-00724.
PMID: 36138171
|
|
|
|